But until we do longer-term studies of which people taking it now, essentially, will be the guinea pigs then were not going to know definitively whether this is going to be safe long term, or whether it is safer as a short-term intervention. But people may not want to only use semaglutide as a short-term measure, because its effects only last as long as people are on it
This idea is supported by real-world evidence
Acetylcarnitine, the shortest metabolite of a class of fatty acid metabolites called acylcarnitines and one of the most abundant blood metabolites in humans can be used as a dietary/nutritional supplement with proven clinical efficacy in the treatment of MDD, ME/CFS and other neuropsychiatric disorders
A companion report for the Peterson-KFF Health System Tracker highlights employers experience with ICHRA and how this nascent market is taking shape.
Most of the evidence comes from animal studies, and while anecdotal reports among humans are promising, rigorous human trials are limited
Neuroprotective Effect of GLP-1RAs Cognitive dysfunction is a neurodegenerative disorder that impairs multiple cognitive domains, including memory, language, executive function, and spatial orientation, with the extent of impairment correlating with disease severity
